Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemiaOussama ElMokh, Michel A. Duchosal, Karin Schaeuble et al.|Cell Death and Disease|2022Cited by 16
Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological MalignanciesPaulina Biniecka, Aimable Nahimana, Saki Matsumoto et al.|Molecules|2023Cited by 8
Nicotinaldehyde, a Novel Precursor of NAD Biosynthesis, Abrogates the Anti-Cancer Activity of an NAD-Lowering Agent in LeukemiaSaki Matsumoto, Aimable Nahimana|Cancers|2023Cited by 4